6:05 PM
 | 
Feb 08, 2013
 |  BC Extra  |  Top Story

White House: sequestration to hinder approvals

The White House said budget sequestration would lead to delays in new drug approvals and reduce FDA's ability to meet PDUFA V commitments. In a statement on Friday, the Obama administration said if sequestration occurs, FDA's Center for Drug Evaluation and Research (CDER) would "face delays in translating new science and technologies into...

Read the full 245 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >